FDA Investigator Ralph A Erickson

Ralph A Erickson has inspections in 9 countries as of 02 Nov 2023. Ralph A Erickson has collaborated with a combinined 5304 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
26
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
France, India, United States of America, Netherlands, Germany, Latvia, United Kingdom of Great Britain and Northern Ireland, Ireland, Sweden
Co-Investigator(s):
Alberto A Viciedo, Alicia Gilbert, Alicia M Mozzachio, Amanda L Baskin, Amy Devlin, PhD, Amy M Cramer, Anders W Evenson, Andrew Chang, Andrew J Lang, Angela E Glenn, Ann Marie Montemurro, Ann Marie Schofield, Atul J Agrawal, Ava M Bowman, Azza Talaat, Barbara L Rogolsky, Barbara M Frazier, Barry Cherney, PhD, Benjamin J Dastoli, Benjamin J Smith, Bonita S Chester, Bradley Dworak, PhD, Brentley S Collins, Brian D Garthwaite, Brian D Nicholson, Brittani N Franklin, Brittany D Terhar, Bruce H Mccullough, Burnell M Henry, Byungja E Marciante, Carl Lee, Carrie Ann Plucinski, Caryn M Mcnab, Catherine V Quinlan, CDR Donald Ertel, Charles I Ann, Charles M Spyr, Cheng H Yen, Christian D Lynch (CDL), Christina A Miller, Christina V Santos, Christopher D Leach, Christopher R Czajka, Christopher T Middendorf, Constantin Y Philopoulos, Corey K Reno, Corrine M Carter, Cynthia J Lee, MS, Cynthia Jim, CSO, Danial S Hutchison, Daniel B Arrecis, Daniel C Kearns, Daniel J Brown, Daniel J Grabicki, Daniel J Roberts, Daniel Lagasse, Daniel T Lee, Dariusz Galezowski, Darren S Morgan, David A Paterson, David J Gasparovich, David L Duncan, David M Beltran, David Perkins, Dawn C Olenjack, Deborah M Trout, Debra I Love, Dell S Moller, Devaughn Edwards, Dipesh K Shah, Donna A Katz, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Barbara D Paul, PhD, Dr. Guang Gao, PhD, Edwin Melendez, Eileen A Liu, Eliezar Ramos, Elizabeth Ll Edwards, Elmina E Akwo, Emest F Bizjak, Emily J Orban, Enrico Joset Mangahis, Eric M Mueller, PharmD, Erin L Mcfiren, Etty Feller, Felix Maldonado, Frank Wackes, Frederick M Fochner, Frederick M Lochner, French, Gene D Arcy, Gene R Gunn, Geneve M Maxwell, Geneve M Parks, Geneve Maxwell, George R Smith, George Smith, Gerald N Mcgirl, DDS, Helen B Ricalde, Humera Khan, Ifueko Osemwota, Jacob G Lutz, Jacob M Dyer, Jacqueline Mdiaz Albertini, James C Lee, PharmD, James I Giefer, James K Ireland, James L Kenney, DSc, James R Evans, Janet L Bowen, Jason F Chancey, Jawaid Hamid, Jeanne M Morris, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey M Watson, Jennifer C Adams, Jennifer C Johnson, Jennifer L Gustavus, Jennifer L Schmidt, Jennifer M Gogley, Joanne E King, Jogy George, Jonathan G Swoboda, Jorge F Christian, Joris Vanloco, Jose Acruz Gonzalez, Joseph George, Joy Rkozlowski Klena, Jude C Dikes, Julianne C Mccullough, Julie D Bringger, Karen M Kondas, Katherine Szestypalow, Kathleen D Culver, Kevin P Foley, Kham Phommachanh, Kula N Jha, Larry K Austin, Latoya A Griffith, Laureen M Geniusz, Laurel A Beer, LCDR Debra Emerson, LCDR Mark A Jimenez, RN, Leigh Anne Myers, Lequita M Mayhew, Leslie A Paul, Linda Thai, Lisa L Flores, Lisa M Bellows, Lisa M Feola, Lorelei S Jarrell, Lori P Peters, Lori S Lawless, Luella J Rossi, Luis M Burgos Medero, Lynda L Lanning, Marcellinus D Dordunoo, Marisa E Stock, Mariza M Jafary, Mark E Parmon, Martha Sullivan Myrick, Martin R Vowell, Mary E Storch, Mary T Carden, Matthew B Casale, Matthew J Gretkierewicz, Maya M Davis, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Michael A Charles, Michael E Clark, Michael P Sheehan, Michael R Goga, Michael Y Philopoulos, Michele L Forster, PhD, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Mihaly S Ligmond, Milva E Melendez, Milva Emelendez Perales, Mra Davism, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Myra K Casey, Nancy E Kirschbaum, Nancy T Waites, Nicholas F Lyons, Nicholas L Paulin, Nicholas P Diorio, Nicole J Clausen, Nicole K Trudel, Noreen Muniz, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia A Cochran, Patricia D Gardner, Patricia H Dlugosz, Patsy I Domingo, Patsy J Domingo, Paul A Bonneau, Paul L Bellamy, Paula A Trost, Paula J Bretz, Peng Zhou, Peter E Baker, Philip A Klimkewicz, Phung Thien Nguyen, Prabhu P Raju, Qiao Y Bobo, Qin Xu, Rafael E Arroyo, Rajiv R Srivastava, Raymond R Roy, PhD, Raymond T Oji, Rebecca E Dombrowski, Rebecca K Olin, Regina T Brown, Richard Heath Coats, Richard W Thornton, Robert C Coleman, Robert D Tollefsen, Robert J Martin, Robert M Barbosa, Robert R Barbosa, Robert W Jennings, Rochelle K Kimmel, Rochelle L Cross, Roman Drews, PhD, Roman T Drews, PhD, Rona Leblanc, PhD, Ronald G Crawford, Ronald T Nowalk, Rose M Ashley, Russ R Rivy, Russell K Riley, Saleem A Akhtar, Sanket N Patel, Sarah B Tanksley, Sarah E Rhoades, Sarah M Meng, Sarah M Napier, Schwierjohann Schwierjohann, Lindsey, Scott A Golladay, Scott T Ballard, Sean R Bryd, Shana L Williams, Shankar L Saha, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sina Shojaee, Sneha S Patel, Stephanie A Slater, MS, Stephen D Brown, Stephen J Kilker, Steven A Gonzales, Steven P Donald, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Tamara M Kays, Tammy L Chavis, Tara R Gooen, Teresita C Mercado, Terri L Dodds, Theresa L Stewart, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thomas S Arista, Tiara Nbrown Crosen, Timothy C Schell, Todd M Stankewicz, Tonnie L Carter, Torrance J Slayton, Tracey Asinjen Wiersma, Troy C Quander, Vijaya L Simhadri, Wayne E Seifert, Wei Wang, PhD, Wendy G Tan, PhD, Wenzheng Zhang, William D Tingley, William J Leonard, Yonggang Wang, PhD, Yumi J Hiramine, Yvonne E Lozano, Zuben E Sauna, PhD

Ralph A Erickson's Documents

Publish Date Document Type Title
March, 2000 EIR Wockhardt Limited - EIR, 2000-03-14
August, 2002 FDA 483 AbbVie Inc. - Form 483, 2002-08-15
December, 2002 EIR Charles River Laboratories, Inc. DBA Charles River, Endosafe - EIR, 2002-12-13
November, 2003 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2003-11-25
March, 2000 FDA 483 Response Wockhardt Limited - Form 483R, 2000-03-17
June, 2003 EIR Labcorp Drug Development Inc. - EIR, 2003-06-13
January, 2002 FDA 483 Technochemie GmbH + Co. KG - Form 483, 2002-01-23
February, 2002 EIR Takeda Ireland Limited - EIR, 2002-02-05
January, 2003 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2003-01-30
August, 2002 FDA 483 Response AbbVie Inc. - Form 483R, 2002-08-28
April, 2003 EIR Haemachem Division Wako Chemicals USA Inc - EIR, 2003-04-21
January, 2003 EIR Pharmacia & Upjohn Company LLC - EIR, 2003-01-30
November, 2003 FDA 483 Response Ben Venue Laboratories Inc. - Form 483R, 2003-11-25
March, 2000 FDA 483 Response Wockhardt Limited - Form 483R, 2000-04-10
January, 2002 EIR Olainfarm JSC - EIR, 2002-01-29
January, 2002 FDA 483 Response Olainfarm JSC - Form 483R, 2002-02-22
December, 2002 FDA 483 Charles River Laboratories, Inc. DBA Charles River, Endosafe - Form 483, 2002-12-13
December, 2003 FDA 483 Ortho Clinical Diagnostics - Form 483, 2003-12-16
April, 2003 FDA 483 Haemachem Division Wako Chemicals USA Inc - Form 483, 2003-04-21
August, 2002 EIR AbbVie Inc. - EIR, 2002-08-15
January, 2003 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2003-02-25
January, 2002 FDA 483 Olainfarm JSC - Form 483, 2002-01-29
September, 2002 EIR Organon Teknika B.V. - bioMerieux, BV - EIR, 2002-09-25
December, 2003 EIR Ortho Clinical Diagnostics - EIR, 2003-12-16
November, 2003 EIR Ben Venue Laboratories Inc. - EIR, 2003-11-25
March, 2000 EIR Wockhardt Limited - EIR, 2000-03-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more